WO2016203040A1 - Endoluminal vascular prostheses and method of deploying such prostheses - Google Patents

Endoluminal vascular prostheses and method of deploying such prostheses Download PDF

Info

Publication number
WO2016203040A1
WO2016203040A1 PCT/EP2016/064166 EP2016064166W WO2016203040A1 WO 2016203040 A1 WO2016203040 A1 WO 2016203040A1 EP 2016064166 W EP2016064166 W EP 2016064166W WO 2016203040 A1 WO2016203040 A1 WO 2016203040A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
stent system
proximal
stentgraft
wire
Prior art date
Application number
PCT/EP2016/064166
Other languages
French (fr)
Inventor
Patrick Berg
Victor Charles BERG
Original Assignee
Benta Pharma Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benta Pharma Industries filed Critical Benta Pharma Industries
Priority to EP16738076.5A priority Critical patent/EP3310299A1/en
Publication of WO2016203040A1 publication Critical patent/WO2016203040A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/077Stent-grafts having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/823Stents, different from stent-grafts, adapted to cover an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0008Rounded shapes, e.g. with rounded corners elliptical or oval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0026Angular shapes trapezoidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0037Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Definitions

  • the present invention relates to endoluminal vascular prostheses and methods of deploying such prostheses. More particularly this invention relates to systems, apparatuses and methods for deploying stents and/or stentgrafts and creating fenestrations in such devices while they are deployed in situ within body lumens, such as blood vessels, to provide additional flow pathways and/or join with other flow-directing or structural devices.
  • An aortic aneurysm is characterized by the dilation of the wall of the aorta. Aortic aneurysms are likely to rupture, especially when the diameter increases, thus posing significant danger to the patient. Rupture of an aneurysm gives only a 20 % chance of survival, so there is a significant emphasis placed on early diagnosis and treatment.
  • Aneurysms of the abdominal and thoracic aorta are a major cause of mortality, especially in the western societies.
  • Stentgrafts are medical devices constructed to reinforce, replace, or bridge a part of a damaged, unhealthy, or diseased blood vessel. The technique has significant limitations and is nor suitable for all patients.
  • a stentgraft at or near an intersection of an artery to be repaired (such as the aorta) with branch vessels (for example the renal arteries, superior mesenteric artery, celiac trunk, brachiocephalic artery, carotid arteries or left subclavian artery etc.) is well recognized.
  • branch vessels for example the renal arteries, superior mesenteric artery, celiac trunk, brachiocephalic artery, carotid arteries or left subclavian artery etc.
  • This technique is easier than the technique for fenestrated
  • chimney grafts in conjunction with polymer-filled endobags which have the ability to conform to adjacent structures may offer advantages over conventional endografts when combined with parallel grafts designed to treat juxtarenal aneurysms (23).
  • the requirements for in vivo fenestration are : obtention of low leak rates, a technique easy to learn and to perform, no wait time using off-the-shelf devices, possibility to treat emergent cases, ostium of target vessels have to be marked easily and
  • ischemia due to temporary occlusion of target vessels has to be prevented and the stentgraft should be flexible enough to deal with a tortuous anatomy. It is the object of the invention to provide a flexible prosthesis with a self- expandable stent allowing blood flow through the struts during cannulation and connection of target vessels with the aortic lumen by the use of stentgrafts. After having connected all the target vessels, the residual lumen between aortic wall and aortic stent is sealed with polymer-filled endobags.
  • the self-expandable stent is cylindrical in shape.
  • An oblique plane cuts the proximal end of the cylinder.
  • the section is an ellipse.
  • the lowest part is meant to be used in an anterior position, below a visceral target vessel, either superior mesenteric artery or celiac trunk for example.
  • the Stent System consists of a closed end, braided self-expanding stent made of Nitinol (nickel-titanium alloy) wire material that is premounted on a delivery system.
  • the over-the-wire (OTW) stent delivery system is compatible with a 0.035" guide wire.
  • the stents contain radiopaque markers at each end and antero-posteriorly allowing to identify the rotation. It also contains a marker at the lowest part of the ellipse. This marker should be placed under the visceral vessel serving as reference.
  • the stent is contained within the outer sheath of the delivery system. Once the distal end of the delivery system reaches the treatment site, the outer sheath of the delivery system is retracted to expose the stent and start its self-expansion.
  • the Vascular Stents are designed to open to a pre-programmed diameter at body temperature.
  • the diameter of the stent is inferior to the diameter of the aorta.
  • the stent remains attached to the catheter allowing minor rotation and height adjustment during implantation.
  • the stent diameter should be chosen according to the diameter of the aortic segment to treat.
  • the difference between aortic and stent diameter should be sufficient to place a parallel graft outside the stent in case of technically difficult access or a target vessel out of reach for an antegrade fenestration. This might occur when the ostium of the target vessel to treat is superposed by the proximal endobag or when the height of the ostium is lower than the portion to fenestrate from the stent system.
  • endobags are fixed on the proximal outer part of the stent. Over these wires, contained endobags can be advanced over the guide wires up to the height of the stent. The endobags are contained in a catheter and released by pulling down the catheter. The endobags are staying connected by small feeder pipes allowing the polymer fill. These endobags are in a longitudinal position at 45°, 135°, 225° and 315°
  • One endobag is attached to the two proximal rings end of the stent following the elliptic shape. This endobag is also connected to a feeder pipe outside the stent allowing polymer fill.
  • the space between aortic wall and stent system around the connected stentgrafts is sealed.
  • the advantage of using endobags not primarily fixed to the stent is to reduce the size of the stent system and to prevent access obstruction to target vessels during cannulation and fenestration.
  • a rhombus is a parallelogram with a 4- sided flat shape with straight sides where all sides have equal length and all opposite sides are parallel and opposite angles are equal.
  • This free space is used to cannulate a target vessel with a guide wire.
  • a stentgraft is advanced over the guide wire into the target vessel.
  • the distal part of the stentgraft is delivered in the proximal part of the target vessel, the proximal part of the stentgraft is delivered in the aortic lumen inside the self-expandable stent.
  • the distance between proximal end of the stentgraft and the rhombus-like wires of the stent is dilated and slightly oversized, preventing a dislocation between stent and connecting stentgraft during manipulations.
  • a technical issue could be to safely cannulate the non-covered stent to create the fenestrations either from the contralateral side or by a subclavian/brachial approach.
  • the fact of matter is, while trying to cannulate the stent with a wire, the wire could go through the struts and jeopardize the procedure.
  • a preloaded contralateral wire will be used and allow to advance an introducer sheath from the contralateral side without any difficulties.
  • the guide wire used to advance the stent system will be catched by a snare catheter from the
  • the distances between the different vessels it is mandatory to calculate the distances between the different vessels to treat so as the angles of ostia of the vessels. If for instance the stent should be placed below the superior mesenteric artery, the lowest part of the vessel and the angle will be the center of a new coordinate system thus giving this point the coordinates (0;0). Thus the lowest part of the elliptic ring will have the coordinates (0;-3) due to the fact that a minimum of 3 mm as safe distance should be respected.
  • the ostia of the renal arteries will be projected on the graph giving for x the value for the angle difference between the center of the SMA and the renal arteries.
  • the value for y is the distance between the bottom of the SMA and the top of the renal arteries.
  • the bottom of the celiac axis will have the coordinates (0;0) and all other coordinates will be calculated as described before in this coordinate system.
  • a drawing of the unwrapped cylinder can be done.
  • the ellipse will then have the shape of a sinus curve with period nr and the
  • f(x) a*(l-cos(x/r)), where a is the amplitude ((h2-hl)/2) and x the angle difference of the vessel to treat in relation to the SMA with the coordinates (0;0) and r the radius of the stent.
  • the stent system is released.
  • An existing device to treat infrarenal aortic aneurysms may be attached to the distal part of the stent system, thus completing the procedure.
  • the stent graft system is introduced over a guide wire
  • An introducer sheath is introduced over the preloaded contralateral wire into the stent.
  • the target vessel to fenestrate is cannulated through the struts of the stent with a guide-wire and a diagnostic catheter.
  • a covered stent is introduced into the target vessel
  • a parallel graft may be performed prior to polymer fill outside the stent system in particular cases where a direct fenestration is not possible.
  • Figure 1 shows a perspective view of the over-the-wire
  • FIG. 1 shows a perspective view of the self expandable stent.
  • Figure 3 shows a lateral sketch of the stent.
  • Figure 4 shows the unwrapped cylinder.
  • Figure 5 shows the proximal endobag.
  • Figure 6 shows the lateral endobag.
  • Figure 7 shows the four lateral endobags.
  • Figure 8 and 9 show the fenestration with a stentgraft through the rhombus of the stent.
  • Figure 10 planning of a procedure with projection of the ostia of celiac trunk, superior mesenteric artery, left and right renal artery.
  • Figure 1 shows a perspective view of the over-the-wire (OTW) delivery system, respectively, of a first introducer sheath 4 that glides over a guide wire 1 with a diameter of e.g. 0.035".
  • the first introducer sheath 4 contains a dilator 3.
  • a contralateral wire 2 is attached to the stent system allowing to cannulate the stent system from the contralateral side.
  • the stent 5 is contained within the introducer sheath.
  • Figure 2 shows a perspective view of the self expandable stent 5.
  • the self- expandable stent is cylindrical in shape.
  • An oblique plane cuts the proximal end of the cylinder. As the cutting plane is not
  • the section is an ellipse.
  • Figure 3 shows a lateral sketch of the stent.
  • Figure 4 shows the unwrapped cylinder.
  • Two proximal rings 6 and 7 are fixed to the mesh.
  • the proximal endobag is fixed on the two rings.
  • Four radiopaque markers 8 are fixed on the mesh.
  • the upper marker is fixed on the proximal ring at 0°.
  • Two other markers are fixed on the ventral part of the stent and another marker at 180°. While implanting the stent, the upper marker delivers the information of the height of implantation. The three others deliver the information of rotation of the stent. Under fluoroscopy the three markers should be placed on a line.
  • Figure 5 shows the proximal endobag.
  • This endobag is attached to the two proximal rings end of the stent following the elliptic shape.
  • This endobag is also connected to a feeder pipe outside the stent allowing polymer fill.
  • Figure 6 shows the lateral endobag.
  • a thin guide wire 10 is fixed on the proximal outer part of the stent. Over this wire, a contained endobag 11 can be advanced over the guide wires up to the height of the stent.
  • the endobags are contained in a catheter 12 and released by pulling down the catheter.
  • the endobag is connected by small feeder pipe 13 allowing the polymer fill.
  • the free space between the interwoven nitinol wires 14 has the form of a rhombus.
  • the target vessel is cannulated through this spacel with a guide wire.
  • a stentgraft 15 is advanced over the guide wire into the target vessel.
  • the proximal part of the stentgraft is delivered in the aortic lumen inside the self-expandable stent and is dilated and slightly oversized 16, preventing a dislocation between stent and connecting stentgraft during manipulations.
  • CA Celiac Axis
  • the stent system consists of a closed end, braided self- expanding stent made of Nitinol 5 (nickel-titanium alloy) wire material that is premounted on a delivery system.
  • the over- the-wire (OTW) stent delivery system is compatible with a 0.035" guide wire 1.
  • the stent system has a diameter inferior of the diameter of the aorta.
  • the stent remains attached to the catheter allowing minor rotation and height adjustment during implantation.
  • the stent system further comprises a proximal end cut in an oblique plane antero-posteriorly transforming the section in an ellipse.
  • the stent system further comprises a contralateral preloaded wire 2 allowing cannulation of the stent without difficulties.
  • the stent system further comprises four radiopaque markers 8, allowing height and rotation control.
  • the stent system has two proximal rings 6 and 7 with an elliptic shape.
  • the stent system furthers compries an endobag 9 which is mounted on the two proximal rings.
  • the endobag furthers compries a feeder pipe 13 which allows polymer fill and sealing of the proximal rings.
  • the stent system furthers compries four thin guide wires 10 which are fixed outside the stent system to the proximal rings at 45°, 135°, 225° and 315°.
  • the stent system furthers compries four lateral endobags 11 which are advanced over the guide wires 10 to the proximal end of the stent.
  • Feeder pipes 13 allow polymer fill of the endobags.
  • the free space between the interwoven nitinol wires 14 has the form of a rhombus.
  • Method for fenestrating a stentgraft 5 located in a blood vessel, which branches into a branch vessel comprising the following step: the target vessel is cannulated through the struts of the stent system with a guide wire and a stentgraft is advanced over this guide wire into the target vessel.
  • the method may further comprise the step: the proximal part of the stentgraft 15 is placed inside the mesh of the stent 14 and overdilated 16 to prevent dislocation.
  • the method may further comprise the step: polymer fill of the endobags seals the space between the stent system and the aortic wall around the connecting stentgrafts.

Abstract

The present invention relates to endoluminal vascular prostheses and methods of deploying such prostheses. More particularly this invention relates to systems, apparatuses and methods for deploying stents and/or stentgrafts and creating fenestrations in such devices while they are deployed in situ within body lumens, such as blood vessels, to provide additional flow pathways and/or join with other flow‐directing or structural devices. It is the object of the invention to provide a flexible endovascular device implanted in the aorta with a self‐expandable stent allowing blood flow through the struts during implantation and during cannulation and connection of target vessels with the aortic lumen by the use of stentgrafts. After connection of all the target vessels, the residual lumen between aortic wall and aortic stent is sealed with polymer‐filled endobags.

Description

Endoluminal vascular prostheses and
method of deploying such prostheses
1. FIELD OF THE INVENTION
The present invention relates to endoluminal vascular prostheses and methods of deploying such prostheses. More particularly this invention relates to systems, apparatuses and methods for deploying stents and/or stentgrafts and creating fenestrations in such devices while they are deployed in situ within body lumens, such as blood vessels, to provide additional flow pathways and/or join with other flow-directing or structural devices.
2. BACKGROUND OF THE INVENTION
In the following we refer to a list of references at the end of the description.
An aortic aneurysm is characterized by the dilation of the wall of the aorta. Aortic aneurysms are likely to rupture, especially when the diameter increases, thus posing significant danger to the patient. Rupture of an aneurysm gives only a 20 % chance of survival, so there is a significant emphasis placed on early diagnosis and treatment. (1)
Aneurysms of the abdominal and thoracic aorta are a major cause of mortality, especially in the western societies. With an
increasingly ageing society, the incidence of aneurysm, particular abdominal aortic aneurysm, continues to rise.
Surgical repair of aneurysm is a major and invasive undertaking and there has been much effort in developing less invasive methods. Endovascular repair of aneurysms, using stentgrafts, is now accepted the method of choice(2). Stentgrafts are medical devices constructed to reinforce, replace, or bridge a part of a damaged, unhealthy, or diseased blood vessel. The technique has significant limitations and is nor suitable for all patients.
Hostile neck anatomy has been described with higher rates of early (intraoperative) type I endoleak and intervention (3)(4)(5). Off-label use of a stentgraft is associated with a greater risk of type I
endoleak. (6)(7)(8).
The difficulty of using a stentgraft at or near an intersection of an artery to be repaired (such as the aorta) with branch vessels (for example the renal arteries, superior mesenteric artery, celiac trunk, brachiocephalic artery, carotid arteries or left subclavian artery etc.) is well recognized.
Moreover, the numerous anatomic variations of the visceral arteries make it impossible to use a ready-to-use stentgraft.
(9)(10)(11)(12)(13)
For such patients, endovascular repair is only possible using unique, individually designed and manufactured endografts having
appropriate branch grafts or fenestrations, which match the patient's anatomy. Whilst such grafts can be obtained
commercially, for example the Zenith device of COOK (14)(15) or the fenestrated Anaconda graft from VASCUTEK (16), the
meticulous design of such grafts is reliant on accurate preoperative imaging data.
Procedures with custom-made fenestrated stentgrafts are
technically challenging and require a long learning curve. Moreover the use of patient-specific designed grafts is expensive and requires significant pre- planning so that such grafts are not available in emergency situations.
Proof of concept for off-the-shelf fenestrated devices (VENTANA fenestrated system, COOK Zenith p-branch) for the endovascular repair of juxtarenal and pararenal aortic aneurysms in selected patients has been demonstrated. But nearly 40% of juxtarenal or pararenal aneurysms do not meet anatomical criteria for
endovascular repair using one of the two devices, justifying need for additional designs (17).
The use of parallel "chimney" grafts has been described to treat juxta- and pararenal aneurysms. (18)(19)(20)(21)(22).
This technique is easier than the technique for fenestrated
stentgrafts. Treatment of emergency cases is possible. However there is a higher leak rate (5-15%) compared to fenestrated
stentgrafts (2-5%). The use of chimney grafts in conjunction with polymer-filled endobags which have the ability to conform to adjacent structures may offer advantages over conventional endografts when combined with parallel grafts designed to treat juxtarenal aneurysms (23).
The desirability of conducting in vivo (in situ) fenestration of a graft has been recognized (24). McWilliams describe the fenestration of a thoracic graft by passing a guide wire down the branch artery to pierce the fabric of the graft and then expanding the hole formed by inflation of a balloon. However, whilst the technique described shows that in situ fenestration is possible, it requires percutaneous retrograde access to the branch vessel for correct location of the fenestration. Such is possible for branches of the aortic arch (25) but not for visceral vessels such as the renal or mesenteric arteries. Retrograde Fenestration for visceral vessels has been described before (26) but only in animal experiments. An alternative approach is to puncture the graft fabric in an antegrade fashion. Such a technique has been described using radiofrequency based apparatus (27), needle puncture of bloused section (28)(29)(30), magnetic location and needle puncture (31), needle puncture (32), piercing catheter (33), stent (34), steerable catheter and puncture (35), temporary„chimney" (36) or
sidebranch stentgraft (37).
The requirements for in vivo fenestration are : obtention of low leak rates, a technique easy to learn and to perform, no wait time using off-the-shelf devices, possibility to treat emergent cases, ostium of target vessels have to be marked easily and
cannulated without difficulty, ischemia due to temporary occlusion of target vessels has to be prevented and the stentgraft should be flexible enough to deal with a tortuous anatomy. It is the object of the invention to provide a flexible prosthesis with a self- expandable stent allowing blood flow through the struts during cannulation and connection of target vessels with the aortic lumen by the use of stentgrafts. After having connected all the target vessels, the residual lumen between aortic wall and aortic stent is sealed with polymer-filled endobags.
3. SUMMARY OF THE INVENTION
3.1. Stent System According to the invention, the self-expandable stent is cylindrical in shape. An oblique plane cuts the proximal end of the cylinder. As the cutting plane is not perpendicular to the axis, the section is an ellipse. The lowest part is meant to be used in an anterior position, below a visceral target vessel, either superior mesenteric artery or celiac trunk for example.
Depending on the angle (β) of the cutting of the stent, the height of the dorsal part of the stent extends the height of the ventral part by the value of the diameter of the stent multiplied by tangent of β: h2-hl= d*tan( ), where d = diameter of the stent.
The Stent System consists of a closed end, braided self-expanding stent made of Nitinol (nickel-titanium alloy) wire material that is premounted on a delivery system. The over-the-wire (OTW) stent delivery system is compatible with a 0.035" guide wire. The stents contain radiopaque markers at each end and antero-posteriorly allowing to identify the rotation. It also contains a marker at the lowest part of the ellipse. This marker should be placed under the visceral vessel serving as reference.
The stent is contained within the outer sheath of the delivery system. Once the distal end of the delivery system reaches the treatment site, the outer sheath of the delivery system is retracted to expose the stent and start its self-expansion.
The Vascular Stents are designed to open to a pre-programmed diameter at body temperature. The diameter of the stent is inferior to the diameter of the aorta. The stent remains attached to the catheter allowing minor rotation and height adjustment during implantation.
The stent diameter should be chosen according to the diameter of the aortic segment to treat. The difference between aortic and stent diameter should be sufficient to place a parallel graft outside the stent in case of technically difficult access or a target vessel out of reach for an antegrade fenestration. This might occur when the ostium of the target vessel to treat is superposed by the proximal endobag or when the height of the ostium is lower than the portion to fenestrate from the stent system.
3.2. Endobags
Several thin guide wires are fixed on the proximal outer part of the stent. Over these wires, contained endobags can be advanced over the guide wires up to the height of the stent. The endobags are contained in a catheter and released by pulling down the catheter. The endobags are staying connected by small feeder pipes allowing the polymer fill. These endobags are in a longitudinal position at 45°, 135°, 225° and 315°
One endobag is attached to the two proximal rings end of the stent following the elliptic shape. This endobag is also connected to a feeder pipe outside the stent allowing polymer fill.
When the endobags are filled with polymer, the space between aortic wall and stent system around the connected stentgrafts is sealed.
Once the polymer has hardened the connecting pipes with the thin wires will be pulled out.
The advantage of using endobags not primarily fixed to the stent is to reduce the size of the stent system and to prevent access obstruction to target vessels during cannulation and fenestration.
3.3. Fenestration The free space between the interwoven nitinol wires has the form of a rhombus. Per definition, a rhombus is a parallelogram with a 4- sided flat shape with straight sides where all sides have equal length and all opposite sides are parallel and opposite angles are equal.
This free space is used to cannulate a target vessel with a guide wire. Once all the target vessels are cannulated, a stentgraft is advanced over the guide wire into the target vessel. The distal part of the stentgraft is delivered in the proximal part of the target vessel, the proximal part of the stentgraft is delivered in the aortic lumen inside the self-expandable stent. The distance between proximal end of the stentgraft and the rhombus-like wires of the stent is dilated and slightly oversized, preventing a dislocation between stent and connecting stentgraft during manipulations.
A technical issue could be to safely cannulate the non-covered stent to create the fenestrations either from the contralateral side or by a subclavian/brachial approach. The fact of matter is, while trying to cannulate the stent with a wire, the wire could go through the struts and jeopardize the procedure. To prevent this, a preloaded contralateral wire will be used and allow to advance an introducer sheath from the contralateral side without any difficulties. For the subclavian/brachial approach the guide wire used to advance the stent system will be catched by a snare catheter from the
subclavian/brachial approach and a long introducer sheath will be introduced from above over this wire. The end of the introducer sheath will be placed into the self-expandable stent.
3.4. Planning
During planning of the procedure it is mandatory to calculate the distances between the different vessels to treat so as the angles of ostia of the vessels. If for instance the stent should be placed below the superior mesenteric artery, the lowest part of the vessel and the angle will be the center of a new coordinate system thus giving this point the coordinates (0;0). Thus the lowest part of the elliptic ring will have the coordinates (0;-3) due to the fact that a minimum of 3 mm as safe distance should be respected. The ostia of the renal arteries will be projected on the graph giving for x the value for the angle difference between the center of the SMA and the renal arteries. The value for y is the distance between the bottom of the SMA and the top of the renal arteries. If the stent is planned to be deployed between the celiac axis and the SMA, the bottom of the celiac axis will have the coordinates (0;0) and all other coordinates will be calculated as described before in this coordinate system. A drawing of the unwrapped cylinder can be done. The ellipse will then have the shape of a sinus curve with period nr and the
formula: f(x)= a*(l-cos(x/r)), where a is the amplitude ((h2-hl)/2) and x the angle difference of the vessel to treat in relation to the SMA with the coordinates (0;0) and r the radius of the stent.
3.5. Additional procedures
Once all the vessels fenestrated and endobags filled, the stent system is released. An existing device to treat infrarenal aortic aneurysms may be attached to the distal part of the stent system, thus completing the procedure.
3.6. Summary
- The stent graft system is introduced over a guide wire
with a contralateral preloaded wire and positioned below the reference target vessel.
- The stent is released but the stent will stay attached to the stent system to allow rotation and height adjustments.
- An introducer sheath is introduced over the preloaded contralateral wire into the stent. The target vessel to fenestrate is cannulated through the struts of the stent with a guide-wire and a diagnostic catheter.
- A covered stent is introduced into the target vessel
through the struts, the proximal part staying inside the stent and overdilated to prevent dislocation.
- Contained endobags are advanced over preloaded wires up to the proximal end of the stent where another endobag is attached to the proximal ring following the elliptic shape.
- All endobags are filled with polymer.
- The stent is finally released completely and the
procedure is finished by attaching to the device a traditional stentgraft.
- A parallel graft may be performed prior to polymer fill outside the stent system in particular cases where a direct fenestration is not possible.
4. BRIEF DESCRIPTION OF THE DRAWINGS
Further features and advantages of the invention can be derived from the following description which explains the invention in more detail on the basis of embodiments in connection with the enclosed Figures, wherein:
Figure 1 shows a perspective view of the over-the-wire
(OTW) stent delivery system compatible with a 0.035" guide wire. Figure 2 shows a perspective view of the self expandable stent.
Figure 3 shows a lateral sketch of the stent.
Figure 4 shows the unwrapped cylinder.
Figure 5 shows the proximal endobag.
Figure 6 shows the lateral endobag.
Figure 7 shows the four lateral endobags.
Figure 8 and 9 show the fenestration with a stentgraft through the rhombus of the stent.
Figure 10 planning of a procedure with projection of the ostia of celiac trunk, superior mesenteric artery, left and right renal artery.
5. DETAILED DESCRIPTION OF THE
INVENTION
Figure 1 shows a perspective view of the over-the-wire (OTW) delivery system, respectively, of a first introducer sheath 4 that glides over a guide wire 1 with a diameter of e.g. 0.035". The first introducer sheath 4 contains a dilator 3. A contralateral wire 2 is attached to the stent system allowing to cannulate the stent system from the contralateral side. The stent 5 is contained within the introducer sheath.
Figure 2 shows a perspective view of the self expandable stent 5. The self- expandable stent is cylindrical in shape. An oblique plane cuts the proximal end of the cylinder. As the cutting plane is not
perpendicular to the axis, the section is an ellipse.
Figure 3 shows a lateral sketch of the stent. Depending on the angle (β) of the cutting of the stent, the height of the dorsal part of the stent extends the height of the ventral part by the value of the diameter of the stent multiplied by tangent of β: h2-hl= d*tan( ), where d = diameter of the stent.
Figure 4 shows the unwrapped cylinder. The ellipse will then have the shape of a sinus curve with period nr and the formula: f(x)=a*(l-cos(x/r)), where a is the amplitude ((h2-hl)/2) and r the radius of the stent. Two proximal rings 6 and 7 are fixed to the mesh. The proximal endobag is fixed on the two rings. Four radiopaque markers 8 are fixed on the mesh. The upper marker is fixed on the proximal ring at 0°. Two other markers are fixed on the ventral part of the stent and another marker at 180°. While implanting the stent, the upper marker delivers the information of the height of implantation. The three others deliver the information of rotation of the stent. Under fluoroscopy the three markers should be placed on a line.
Figure 5 shows the proximal endobag. This endobag is attached to the two proximal rings end of the stent following the elliptic shape. This endobag is also connected to a feeder pipe outside the stent allowing polymer fill. Figure 6 shows the lateral endobag. A thin guide wire 10 is fixed on the proximal outer part of the stent. Over this wire, a contained endobag 11 can be advanced over the guide wires up to the height of the stent. The endobags are contained in a catheter 12 and released by pulling down the catheter. The endobag is connected by small feeder pipe 13 allowing the polymer fill.
Figure 7
Four endobags in total are placed in a longitudinal position at 45°, 135°, 225° and 315°
Figure 8 and 9
The free space between the interwoven nitinol wires 14 has the form of a rhombus. The target vessel is cannulated through this spacel with a guide wire. A stentgraft 15 is advanced over the guide wire into the target vessel. The proximal part of the stentgraft is delivered in the aortic lumen inside the self-expandable stent and is dilated and slightly oversized 16, preventing a dislocation between stent and connecting stentgraft during manipulations.
Figure 10 example of procedure planning:
Bottom SMA: Coordinates (0;0) diameter 7 mm
Celiac Axis (CA) : +15° to SMA, diameter 9 mm, distance CA-SMA 12 mm
Right renal artery: -67° to SMA, diameter 6 mm, distance to SMA 8 mm Left renal artery: +75° to SMA, diameter 6 mm, distance to SMA 3 mm tent radius 11 mm. Angle β 30° safety distance bottom SMA proximal ring 3 mm
The stent system consists of a closed end, braided self- expanding stent made of Nitinol 5 (nickel-titanium alloy) wire material that is premounted on a delivery system. The over- the-wire (OTW) stent delivery system is compatible with a 0.035" guide wire 1.
The stent system has a diameter inferior of the diameter of the aorta. The stent remains attached to the catheter allowing minor rotation and height adjustment during implantation.
The stent system further comprises a proximal end cut in an oblique plane antero-posteriorly transforming the section in an ellipse.
The stent system further comprises a contralateral preloaded wire 2 allowing cannulation of the stent without difficulties.
The stent system further comprises four radiopaque markers 8, allowing height and rotation control.
The stent system has two proximal rings 6 and 7 with an elliptic shape.
The stent system furthers compries an endobag 9 which is mounted on the two proximal rings. The endobag furthers compries a feeder pipe 13 which allows polymer fill and sealing of the proximal rings.
The stent system furthers compries four thin guide wires 10 which are fixed outside the stent system to the proximal rings at 45°, 135°, 225° and 315°.
The stent system furthers compries four lateral endobags 11 which are advanced over the guide wires 10 to the proximal end of the stent. Feeder pipes 13 allow polymer fill of the endobags.
The free space between the interwoven nitinol wires 14 has the form of a rhombus.
Method for fenestrating a stentgraft 5 located in a blood vessel, which branches into a branch vessel, comprising the following step: the target vessel is cannulated through the struts of the stent system with a guide wire and a stentgraft is advanced over this guide wire into the target vessel.
The method may further comprise the step: the proximal part of the stentgraft 15 is placed inside the mesh of the stent 14 and overdilated 16 to prevent dislocation.
The method may further comprise the step: polymer fill of the endobags seals the space between the stent system and the aortic wall around the connecting stentgrafts.
In case a target vessel cannot be cannulated through the struts, a parallel graft outside the stentsystem can be placed and sealed as described before. EFERENCES Perko MJ, Schroeder TV, Olsen PS, Jensen LP, Lorentzen JE. Natural history of abdominal aortic aneurysm: a survey of 63 patients treated nonoperatively. Ann Vase Surg [Internet].
1993 [cited 2013 Aug 26];7(2):113-6. Available from:
http://www.sciencedirect.com/science/article/pii/S08905096 0660 5785. Albuquerque FCJ, Tonnessen BH, Noll REJ, Ores G, Kim JK, Sternbergh WC 3rd. Paradigm shifts in the treatment of abdominal aortic aneurysm: trends in 721 patients between 1996 and 2008. J Vase Surg. 2010 Jun;51(6):1348-52;
discussion 1352-3. Hobo R, Kievit J, Leurs LJ, Buth J. Influence of severe infrarenal aortic neck angulation on complications at the proximal neck following endovascular AAA repair: a EUROSTAR study. J
Endovasc Ther Off J Int Soc Endovasc Spec. 2007 Feb;14(l). Leurs LJ, Kievit J, Dagnelie PC, Nelemans PJ, Buth J. Influence of infrarenal neck length on outcome of endovascular
abdominal aortic aneurysm repair. J Endovasc Ther Off J Int Soc Endovasc Spec. 2006 Oct;13(5):640-8. Aburahma AF, Campbell JE, Mousa AY, Hass SM, Stone PA, Jain A, et al. Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices. J Vase Surg. 2011 Jul;54(l). Antoniou GA, Georgiadis GS, Antoniou SA, Kuhan G, Murray D. A meta-analysis of outcomes of endovascular abdominal aortic aneurysm repair in patients with hostile and friendly neck anatomy. J Vase Surg. 2013 Feb;57(2):527-38. Schanzer A, Greenberg RK, Hevelone N, Robinson WP, Eslami MH, Goldberg RJ, et al. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair.
Circulation. 2011 Jun 21;123(24):2848-55. Troisi N, Torsello G, Weiss K, Donas KP, Michelagnoli S,
Austermann M. Midterm Results of Endovascular Aneurysm Repair Using the Endurant Stent-Graft According to the
Instructions for Use vs. Off-Label Conditions. J Endovasc Ther [Internet]. 2014 Dec [cited 2015 Apr 28];21(6):841-7.
Available from: http://jevtonline.org/doi/abs/10.1583/14- 4795MR.1. Garcier JM, De Fraissinette B, Filaire M, Gayard P, Therre T, Ravel A, et al. Origin and initial course of the renal arteries: a radiological study. Surg Radiol Anat SRA. 2001;23(l):51-5. Ozan H, Alemdaroglu A, Sinav A, Gumusalan Y. Location of the ostia of the renal arteries in the aorta. Surg Radiol Anat SRA. 1997;19(4):245-7. Sampaio FJB, Passos M. Renal arteries: anatomic study for surgical and radiological practice. Surg Radiol Anat [Internet]. 1992 [cited 2013 Sep 4];14(2):113-7. Available from:
http://link.springer.com/article/10.1007/BF01794885. Toni R, Mosca S, Favero L, Ricci S, Roversi R, Toni G, et al.
Clinical anatomy of the suprarenal arteries: a quantitative approach by aortography. Surg Radiol Anat [Internet]. 1988 [cited 2013 Sep 4];10(4):297-302. Available from:
http://link.springer.com/article/10.1007/BF02107902. Beregi JP, Mauroy B, Willoteaux S, Mounier-Vehier C, Remy- Jardin M, Francke J. Anatomic variation in the origin of the main renal arteries: spiral CTA evaluation. Eur Radiol.
1999;9(7):1330-4. Verhoeven ELG, Tielliu IFJ, Muhs BE, Bos W, Zeebregts CJ, Prins TR, et al. Fenestrated and branched stent-grafting: a 5-years experience. Acta Chir Belg [Internet]. 2006 [cited 2013 Aug 26];106(3):317. Available from:
http://www.belsurg.org/uploaded_pdfs/106/106_317_322.pd f. Mertens J, Houthoofd S, Daenens K, Fourneau I, Maleux G, Lerut P, et al. Long-term results after endovascular abdominal aortic aneurysm repair using the Cook Zenith endograft. J Vase Surg [Internet]. 2011 Jul [cited 2013 Sep 3];54(l):48-57.e2. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S07415214110010 66. Bungay PM, Burfitt N, Sritharan K, Muir L, Khan SL, De Nunzio MC, et al. Initial experience with a new fenestrated stent graft. J Vase Surg [Internet]. 2011 Dec [cited 2013 Sep
3];54(6):1832-8. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S07415214110148 81. Mendes BC. Anatomical Feasibility of Off-the-Shelf
Fenestrated Stent Grafts to Treat Juxtarenal and Pararenal Abdominal Aortic Aneurysms. 2013. Bruen KJ, Feezor RJ, Daniels MJ, Beck AW, Lee WA.
Endovascular chimney technique versus open repair of juxtarenal and suprarenal aneurysms. J Vase Surg [Internet]. 2011 Apr [cited 2013 Aug 26];53(4):895-905. Available from: http://linkinghub.elsevier.com/retrieve/pii/S07415214100245 96. Coscas R, Kobeiter H, Desgranges P, Becquemin J-P. Technical aspects, current indications, and results of chimney grafts for juxtarenal aortic aneurysms. J Vase Surg [Internet]. 2011 Jun [cited 2013 Aug 26];53(6):1520-7. Available from:
http://linkinghub.elsevier.com/retrieve/pii/S07415214110023 33. Suominen V, Pimenoff G, Salenius J. Fenestrated and Chimney Endografts for Juxtarenal Aneurysms: Early and Midterm Results. Scand J Surg [Internet]. 2013 [cited 2013 Aug
26];102(3):182-8. Available from:
http://sjs.sagepub.eom/content/102/3/182.abstract. Tolenaar JL, Zandvoort HJA, Moll FL, van Herwaarden JA.
Technical considerations and results of chimney grafts for the treatment of juxtarenal aneursyms. J Vase Surg [Internet]. 2013 Sep [cited 2013 Aug 26];58(3):607-15. Available from: http://linkinghub.elsevier.com/retrieve/pii/S07415214130054 8X. Bin Jabr A, Sonesson B, Lindblad B, Dias N, Resch T, Malina M. Chimney grafts preserve visceral flow and allow safe stenting of juxtarenal aortic occlusion. J Vase Surg. 2013 Feb;57(2). Malkawi AH, de Bruin JL, Loftus IM, Thompson MM.
Treatment of a juxtarenal aneurysm with the Nellix
endovascular aneurysm sealing system and chimney stent. J Endovasc Ther Off J Int Soc Endovasc Spec. 2014
Aug;21(4):538-40. McWilliams RG, Murphy M, Hartley D, Lawrence-Brown MM, Harris PL. In situ stent-graft fenestration to preserve the left subclavian artery. J Endovasc Ther [Internet]. 2004 [cited 2014 Jan 31];ll(2):170-4. Available from:
http://www.jevt.Org/doi/abs/10.1583/03-1180.l. Manning BJ, Ivancev K, Harris PL. In situ fenestration in the aortic arch. J Vase Surg. 2010 Aug;52(2):491-4. McWilliams RG, Fearn SJ, Harris PL, Hartley D, Semmens JB, Lawrence-Brown MM. Retrograde fenestration of endoluminal grafts from target vessels: feasibility, technique, and potential usage. J Endovasc Ther [Internet]. 2003 [cited 2014 Jan
31];10(5):946-52. Available from:
http://www.jevt.org/doi/abs/10.1583/1545- 1550(2003)010%3C0946%3ARFOEGF%3E2.0.CO%3B2. Biadillah Y, Hartley A, Davies G, Visram N, Juzkiw T. Stent Graft Fenestration. US 2012/0046657 Al, 2012. Bruszewski W, Rust M, Greenan T. Device and Method for Stent Graft Fenestration In Situ. WO 2009/064672 A2, 2009. Bruszewski W. Bloused Stent-Graft and Fenestration Method. US 2011/0295355 Al, 2011. Bruszewski W, Greenan T, Chu J, Erickson D, Morris J, Ganesan P, et al. Fenestration Segment Stent-Graft And Fenestration Method. US2009259290A1, 2009. Berg P. Magnetic apparatus for in situ location of a graft fenestration site and method of using same [Internet]. WO 2009/056644 Al, 2010 [cited 2013 Aug 26]. Available from: https://www.google.com/patents/WO2009056644A17chen. Mafi M, Bruszewski W. Stent Graft Delivery System Including Support For Fenestration in Situ and a Mechanism for
Modeling. US 2009/0264988 Al, 2009. McLachlan CS, Mossop P, Nixon I. Method and Device For Graft Fenestration. US2010106175A1, 2010. Naor G, Ackerman H. Method of Implanting a Stent Graft and Creating a Fenestration therein. US 2012/0239132 Al, 2012. Wallace DT, Stahler GJ. In-Situ Graft Fenestration.
2009/0228020 Al, 2009. Wolf YG. Stent Graft Fenestration. US 2012/0041544 Al, 2012. Shaw EE. Stent-Grafts and Devices for in Situ Fenestration of a Stent-Graft at the Site of a Branch Vessel. WO 2012/067823 A3, 2012.

Claims

7. PATENT CLAIMS
1. A stent system comprising a closed end, braided self- expanding stent made of a wire material wherein the stent is premounted on a delivery system.
2. The stent system according to claim 1, wherein the stent is made of a nickel-titanium alloy, especially Nitinol 5.
3. The stent system according to claim 1 or 2, wherein the over- the-wire (OTW) stent delivery system is arranged such that it is compatible with a 0.035" guide wire (1).
4. The stent system according to one of the preceding claims, wherein the stent system has a diameter inferior of the diameter of the aorta.
5. The stent system according to one of the preceding claims, wherein the stent system is arranged such that the stent remains attached to a catheter allowing minor rotation and height adjustment during implantation.
6. The stent system according to one of the preceding claims, further comprising a proximal end cut in an oblique plane antero-posteriorly transforming the section in an ellipse.
7. The stent system according to one of the preceding claims, further comprising a contralateral preloaded wire (2) allowing cannulation of the stent.
8. The stent system according to one of the preceding claims, further comprising four radiopaque markers (8) for height and/or rotation control.
9. The stent system according to one of the preceding claims, wherein the stent system has at least one proximal ring, preferably two proximal rings (6, 7), with an elliptic shape.
10. The stent system according to claim 9, wherein an endobag (9) is mounted on the two proximal rings (6, 7).
11. The stent system according to claim 9 or 10, wherein a feeder pipe (13) allows polymer fill and sealing of the proximal rings (6, 7).
12. The stent system according to one of the preceding claims, wherein four thin guide wires (10) are fixed outside the stent system to the proximal rings (6, 7).
13. The stent system according to claim 12, wherein four thin
guide wires (10) are fixed to the proximal rings with a distance of 90° to one another, especially at 45°, 135°, 225° and 315°.
14. The stent system according to claim 12 or 13, wherein four lateral endobags (11) are advanced over the guide wires (10) to the proximal end of the stent.
15. The stent system according to claim 14, wherein at least one feeder pipe (13) for filling the endobags (11) with a polymer is provided.
16. The stent system according to one of the preceding claims, wherein the free space between the interwoven wires (14) of the stent has the form of a rhombus.
17. Method for fenestrating a stentgraft (5) located in a blood vessel, which branches into a branch vessel, comprising the following step:
- cannulating the target vessel through the struts of the stent system with a guide wire, and
- a advancing the stentgraft (15) over this guide wire into the target vessel.
18. Method according to claim 17, further comprising the step: placing the proximal part of the stentgraft (15) inside the mesh of the stent (14) and overdilating the proximal part of the stentgraft to prevent dislocation.
19. Method according to claim 17 or 18, further comprising the step: filling endobags with a polymer to seal the space
between the stent system and an aortic wall around the connecting stentgrafts.
20. Method according to one of the claims 17 to 19, wherein in case a target vessel cannot be cannulated through the struts, a parallel graft outside the stent system is placed and sealed according to the step of claim 19.
PCT/EP2016/064166 2015-06-18 2016-06-20 Endoluminal vascular prostheses and method of deploying such prostheses WO2016203040A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16738076.5A EP3310299A1 (en) 2015-06-18 2016-06-20 Endoluminal vascular prostheses and method of deploying such prostheses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562181224P 2015-06-18 2015-06-18
US62/181,224 2015-06-18

Publications (1)

Publication Number Publication Date
WO2016203040A1 true WO2016203040A1 (en) 2016-12-22

Family

ID=56409055

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/064166 WO2016203040A1 (en) 2015-06-18 2016-06-20 Endoluminal vascular prostheses and method of deploying such prostheses

Country Status (2)

Country Link
EP (1) EP3310299A1 (en)
WO (1) WO2016203040A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110123501A (en) * 2018-02-08 2019-08-16 柯惠有限合伙公司 Blood vessel distensible devices
WO2020146621A1 (en) * 2019-01-09 2020-07-16 Osf Healthcare System Endovascular stent graft
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
WO1999015103A1 (en) * 1997-09-23 1999-04-01 Carlos Vonderwalde Freidberg Bifurcated stent with flexible side portion
WO2001072240A1 (en) * 2000-03-27 2001-10-04 Aga Medical Corporation Repositionable and recapturable vascular stent/graft
WO2009056644A1 (en) 2007-11-01 2009-05-07 Patrick Berg Magnetic apparatus for in situ location of a graft fenestration site and method of using same
WO2009064672A2 (en) 2007-11-13 2009-05-22 Medtronic Vascular Inc. Device and method for stent graft fenestration in situ
US20090228020A1 (en) 2008-03-06 2009-09-10 Hansen Medical, Inc. In-situ graft fenestration
US20090259290A1 (en) 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Fenestration Segment Stent-Graft and Fenestration Method
US20090264988A1 (en) 2008-04-18 2009-10-22 Medtronic Vascular, Inc. Stent Graft Delivery System Including Support for Fenestration in Situ and a Mechanism for Modeling
US20100106175A1 (en) 2006-01-17 2010-04-29 Mclachlan Criag Steven Method and device for graft fenestration
US20100198329A1 (en) * 2005-07-29 2010-08-05 Cvdevices, Llc Endograft devices and methods for using the same
US20110295355A1 (en) 2008-03-20 2011-12-01 Medtronic Vascular, Inc. Bloused stent-graft and fenestration method
US20120041544A1 (en) 2009-04-02 2012-02-16 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Stent graft fenestration
US20120046657A1 (en) 2007-10-01 2012-02-23 Baylis Medical Company Stent Graft Fenestration
WO2012067823A2 (en) 2010-11-16 2012-05-24 Gore Enterprise Holdings, Inc. Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel
US20120239132A1 (en) 2009-11-30 2012-09-20 Gil Naor Method of implanting a stent graft and creating a fenestration therein
US20140025151A1 (en) * 2012-07-20 2014-01-23 Bulang Gao Retrievable stent for intracranial aneurysms

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
WO1999015103A1 (en) * 1997-09-23 1999-04-01 Carlos Vonderwalde Freidberg Bifurcated stent with flexible side portion
WO2001072240A1 (en) * 2000-03-27 2001-10-04 Aga Medical Corporation Repositionable and recapturable vascular stent/graft
US20100198329A1 (en) * 2005-07-29 2010-08-05 Cvdevices, Llc Endograft devices and methods for using the same
US20100106175A1 (en) 2006-01-17 2010-04-29 Mclachlan Criag Steven Method and device for graft fenestration
US20120046657A1 (en) 2007-10-01 2012-02-23 Baylis Medical Company Stent Graft Fenestration
WO2009056644A1 (en) 2007-11-01 2009-05-07 Patrick Berg Magnetic apparatus for in situ location of a graft fenestration site and method of using same
WO2009064672A2 (en) 2007-11-13 2009-05-22 Medtronic Vascular Inc. Device and method for stent graft fenestration in situ
US20090228020A1 (en) 2008-03-06 2009-09-10 Hansen Medical, Inc. In-situ graft fenestration
US20110295355A1 (en) 2008-03-20 2011-12-01 Medtronic Vascular, Inc. Bloused stent-graft and fenestration method
US20090259290A1 (en) 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Fenestration Segment Stent-Graft and Fenestration Method
US20090264988A1 (en) 2008-04-18 2009-10-22 Medtronic Vascular, Inc. Stent Graft Delivery System Including Support for Fenestration in Situ and a Mechanism for Modeling
US20120041544A1 (en) 2009-04-02 2012-02-16 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Stent graft fenestration
US20120239132A1 (en) 2009-11-30 2012-09-20 Gil Naor Method of implanting a stent graft and creating a fenestration therein
WO2012067823A2 (en) 2010-11-16 2012-05-24 Gore Enterprise Holdings, Inc. Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel
US20140025151A1 (en) * 2012-07-20 2014-01-23 Bulang Gao Retrievable stent for intracranial aneurysms

Non-Patent Citations (26)

* Cited by examiner, † Cited by third party
Title
ABURAHMA AF; CAMPBELL JE; MOUSA AY; HASS SM; STONE PA; JAIN A ET AL.: "Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices", J VASC SURG., vol. 54, no. L, July 2011 (2011-07-01)
ALBUQUERQUE FCJ; TONNESSEN BH; NOLL REJ; CIRES G; KIM JK; STERNBERGH WC: "Paradigm shifts in the treatment of abdominal aortic aneurysm: trends in 721 patients between 1996 and 2008", J VASC SURG., vol. 51, no. 6, June 2010 (2010-06-01), pages 1348 - 52
ANTONIOU GA; GEORGIADIS GS; ANTONIOU SA; KUHAN G; MURRAY D: "A meta-analysis of outcomes of endovascular abdominal aortic aneurysm repair in patients with hostile and friendly neck anatomy", J VASC SURG, vol. 57, no. 2, February 2013 (2013-02-01), pages 527 - 38
BEREGI JP; MAUROY B; WILLOTEAUX S; MOUNIER-VEHIER C; REMY-JARDIN M; FRANCKE J: "Anatomic variation in the origin of the main renal arteries: spiral CTA evaluation", EUR RADIOL., vol. 9, no. 7, 1999, pages 1330 - 4
BIN JABR A; SONESSON B; LINDBLAD B; DIAS N; RESCH T; MALINA M: "Chimney grafts preserve visceral flow and allow safe stenting of juxtarenal aortic occlusion", J VASC SURG., vol. 57, no. 2, February 2013 (2013-02-01)
BRUEN KJ; FEEZOR RJ; DANIELS MJ; BECK AW; LEE WA.: "Endovascular chimney technique versus open repair of juxtarenal and suprarenal aneurysms", J VASC SURG [INTERNET]., vol. 53, no. 4, April 2011 (2011-04-01), pages 895 - 905, XP028155837, Retrieved from the Internet <URL:http://Iinkinghub.elsevier.com/retrieve/pii/S07415214100245 96.> DOI: doi:10.1016/j.jvs.2010.10.068
BUNGAY PM; BURFITT N; SRITHARAN K; MUIR L; KHAN SL; DE NUNZIO MC ET AL.: "Initial experience with a new fenestrated stent graft", J VASC SURG [INTERNET]., vol. 54, no. 6, December 2011 (2011-12-01), pages 1832 - 8, XP028126886, DOI: doi:10.1016/j.jvs.2011.05.115
COSCAS R; KOBEITER H; DESGRANGES P; BECQUEMIN J-P.: "Technical aspects, current indications, and results of chimney grafts for juxtarenal aortic aneurysms", J VASC SURG [INTERNET, vol. 53, no. 6, June 2011 (2011-06-01), pages 1520 - 7, XP028217156, DOI: doi:10.1016/j.jvs.2011.01.067
GARCIER JM; DE FRAISSINETTE B; FILAIRE M; GAYARD P; THERRE T; RAVEL A ET AL.: "Origin and initial course of the renal arteries: a radiological study", SURG RADIOL ANAT SRA, vol. 23, no. 1, 2001, pages 51 - 5, XP019371658, DOI: doi:10.1007/s00276-001-0051-9
HOBO R; KIEVIT J; LEURS LJ; BUTH J.: "Influence of severe infrarenal aortic neck angulation on complications at the proximal neck following endovascular AAA repair: a EUROSTAR study", J ENDOVASC THER OFF J INT SOC ENDOVASC SPEC, vol. 14, no. 1, February 2007 (2007-02-01)
LEURS LJ; KIEVIT J; DAGNELIE PC; NELEMANS PJ; BUTH J.: "Influence of infrarenal neck length on outcome of endovascular abdominal aortic aneurysm repair", J ENDOVASC THER OFF J INT SOC ENDOVASC SPEC, vol. 13, no. 5, October 2006 (2006-10-01), pages 640 - 8
MALKAWI AH; DE BRUIN JL; LOFTUS IM; THOMPSON MM: "Treatment of a juxtarenal aneurysm with the Nellix endovascular aneurysm sealing system and chimney stent", J ENDOVASC THER OFF J INT SOC ENDOVASC SPEC., vol. 21, no. 4, August 2014 (2014-08-01), pages 538 - 40
MANNING BJ; IVANCEV K; HARRIS PL: "In situ fenestration in the aortic arch", J VASC SURG., vol. 52, no. 2, August 2010 (2010-08-01), pages 491 - 4
MCWILLIAMS RG; FEARN SJ; HARRIS PL; HARTLEY D; SEMMENS JB; LAWRENCE-BROWN MM: "Retrograde fenestration of endoluminal grafts from target vessels: feasibility, technique, and potential usage", J ENDOVASC THER [INTERNET, vol. 10, no. 5, 2003, pages 946 - 52
MCWILLIAMS RG; MURPHY M; HARTLEY D; LAWRENCE-BROWN MM; HARRIS PL: "In situ stent-graft fenestration to preserve the left subclavian artery", J ENDOVASC THER [INTERNET, vol. 11, no. 2, 2004, pages 170 - 4
MENDES BC: "Anatomical Feasibility of Off-the-Shelf Fenestrated Stent Grafts to Treat Juxtarenal and Pararenal", ABDOMINAL AORTIC ANEURYSMS, 2013
MERTENS J; HOUTHOOFD S; DAENENS K; FOURNEAU I; MALEUX G; LERUT P ET AL.: "Long-term results after endovascular abdominal aortic aneurysm repair using the Cook Zenith endograf", J VASC SURG [INTERNET, vol. 54, no. 1, July 2011 (2011-07-01), pages 48 - 57
OZAN H; ALEMDAROGLU A; SINAV A; GUMUSALAN Y: "Location of the ostia of the renal arteries in the aorta", SURG RADIOL ANAT SRA., vol. 19, no. 4, 1997, pages 245 - 7, XP019371408
PERKO MJ; SCHROEDER TV; OLSEN PS; JENSEN LP; LORENTZEN JE: "Natural history of abdominal aortic aneurysm: a survey of 63 patients treated nonoperatively", ANN VASC SURG [INTERNET, vol. 7, no. 2, 26 August 2013 (2013-08-26), pages 113 - 6, XP005941037, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/pii/S08905096 0660 5785> DOI: doi:10.1007/BF02001003
SAMPAIO FJB; PASSOS M: "Renal arteries: anatomic study for surgical and radiological practice", SURG RADIOL ANAT [INTERNET]., vol. 14, no. 2, 1992, pages 113 - 7, Retrieved from the Internet <URL:http://link.springer.com/article/10.1007/BF01794885>
SCHANZER A; GREENBERG RK; HEVELONE N; ROBINSON WP; ESLAMI MH; GOLDBERG RJ ET AL.: "Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair", CIRCULATION, vol. 123, no. 24, 21 June 2011 (2011-06-21), pages 2848 - 55
SUOMINEN V; PIMENOFF G; SALENIUS J: "Fenestrated and Chimney Endografts for Juxtarenal Aneurysms: Early and Midterm Results", SCAND J SURG [INTERNET, vol. 102, no. 3, 26 August 2013 (2013-08-26), pages 182 - 8
TOLENAAR JL; ZANDVOORT HJA; MOLL FL; VAN HERWAARDEN JA: "Technical considerations and results of chimney grafts for the treatment of juxtarenal aneursyms", J VASC SURG [INTERNET, vol. 58, no. 3, 26 August 2013 (2013-08-26), pages 607 - 15, XP028696802, Retrieved from the Internet <URL:http://Iinkinghub.elsevier.com/retrieve/pii/S07415214130054 8X> DOI: doi:10.1016/j.jvs.2013.02.238
TONI R; MOSCA S; FAVERO L; RICCI S; ROVERSI R; TONI G ET AL.: "Clinical anatomy of the suprarenal arteries: a quantitative approach by aortography", SURG RADIOL ANAT [INTERNET, vol. 10, no. 4, 1988, pages 297 - 302
TROISI N; TORSELLO G; WEISS K; DONAS KP; MICHELAGNOLI S; AUSTERMANN M: "Midterm Results of Endovascular Aneurysm Repair Using the Endurant Stent-Graft According to the Instructions for Use vs. Off-Label Conditions", J ENDOVASC THER [INTERNET]., vol. 21, no. 6, December 2014 (2014-12-01), pages 841 - 7, Retrieved from the Internet <URL:http://jevtonline.org/doi/abs/10.1583/14-4795MR.1>
VERHOEVEN ELG; TIELLIU IFJ; MUHS BE; BOS W; ZEEBREGTS CJ; PRINS TR ET AL.: "Fenestrated and branched stent-grafting: a 5-years experience", ACTA CHIR BELG [INTERNET, vol. 106, no. 3, 2006, pages 317

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110123501A (en) * 2018-02-08 2019-08-16 柯惠有限合伙公司 Blood vessel distensible devices
CN110123501B (en) * 2018-02-08 2022-01-28 柯惠有限合伙公司 Vascular expandable device
WO2020146621A1 (en) * 2019-01-09 2020-07-16 Osf Healthcare System Endovascular stent graft
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant

Also Published As

Publication number Publication date
EP3310299A1 (en) 2018-04-25

Similar Documents

Publication Publication Date Title
CA2679614C (en) Endovascular deployment device
EP2773287B1 (en) Personalized prosthesis
EP1886645B1 (en) Stent graft sealing zone connecting structure
US10575975B2 (en) Personalized prosthesis and methods of deployment
EP3210568B1 (en) Endovascular stent graft assembly
EP2875796B1 (en) Stent graft assembly for treating branched vessel
EP2837362B1 (en) Assembly for treating branched vessels
EP3310299A1 (en) Endoluminal vascular prostheses and method of deploying such prostheses
US9308107B2 (en) Endoluminal prosthesis and delivery device
Lee Status of branched grafts for thoracic aortic arch endovascular repair
EP2799038B1 (en) Endoluminal prosthesis delivery system
Sultan et al. Abdominal aortic aneurysm repair using the multilayer flow modulator in porcine animal models
Moulakakis et al. The chimney graft technique for preserving renal arteries in stent-graft sealing zones
Biebl et al. Management of a large intraoperative type IIIb endoleak in a bifurcated endograft: A case report
Vourliotakis et al. Endovascular treatment of type Ib endoleak after EVAR using the IBD device: a case report
Macech et al. Balloon-grab technique to bridge steep renal artery during endovascular thoracoabdominal aortic aneurysm repair
Pecoraro et al. Overcoming anatomic limitations to EVAR with chimney and periscope grafts
Bouayed et al. ENDOVASCULAR TREATMENT OF AAA WITH COMPLEX ANATOMIES
Tang et al. Managing difficult aortic necks
Kokkosis et al. Current endovascular treatment of infrarenal abdominal aortic aneurysms and future directions.
AU2008223395B2 (en) Endovascular deployment device
Pirouzram et al. Conduit-Free Retroperitoneal Access to the Iliac Artery in Endovascular Aortic Repair in Patients with Improper Access Vessels
Haulon et al. The Cook Zenith Devices
Kumpati et al. Trans-Carotid Placement of Balloon Expandable Covered Stent for Unplanned Left Carotid Coverage during Endovascular Repair of Distal Arch Aneurysm
RodRiguez-lopez vela™ Proximal endograft system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16738076

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2016738076

Country of ref document: EP